CytoMed Therapeutics (GDTC)

• Market cap: $12M
• 1 day: -6.48%
• 5 days: -12.17%
• 1 month: -12.17%
• 3 months: -1.94%
• 6 months: -33.55%
• Year to date: -27.34%
• 1 year: -54.71%
• 5 years: -74.75%
• 10 years: -74.75%
• Sector: Healthcare
• Industry: Biotechnology

About: CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

Employees: 42